| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, KTTA returned -24.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -58.2% |
| 1 year | -24.8% |
| All-time high | $72.20 (Nov 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in KTTA would be worth today ›No. Pasithea Therapeutics Corp. has not paid a dividend in the past 12 months.
Pasithea Therapeutics Corp. stock trades on NASDAQ under the ticker symbol KTTA.
Pasithea Therapeutics Corp. is part of the Healthcare sector.
Pasithea Therapeutics Corp. has a market cap of 18.02M USD, based on the latest quote.
